Wilkinson D - Search Results

1

Effectiveness of donepezil in reducing clinical worsening in patients with mild-to-moderate alzheimer's disease.

Wilkinson D, Schindler R, Schwam E, Waldemar G, Jones RW, Gauthier S, Lopez OL, Cummings J, Xu Y, Feldman HH. Wilkinson D, et al. Dement Geriatr Cogn Disord. 2009;28(3):244-51. doi: 10.1159/000241877. Epub 2009 Sep 25. Dement Geriatr Cogn Disord. 2009. PMID: 19786776 Free PMC article. Clinical Trial.

2

Rates of cognitive change in Alzheimer disease: observations across a decade of placebo-controlled clinical trials with donepezil.

Jones RW, Schwam E, Wilkinson D, Waldemar G, Feldman HH, Zhang R, Albert K, Schindler R. Jones RW, et al. Among authors: wilkinson d. Alzheimer Dis Assoc Disord. 2009 Oct-Dec;23(4):357-64. doi: 10.1097/WAD.0b013e31819cd4be. Alzheimer Dis Assoc Disord. 2009. PMID: 19561444

3

The long-term efficacy and tolerability of donepezil in patients with vascular dementia.

Wilkinson D, Róman G, Salloway S, Hecker J, Boundy K, Kumar D, Posner H, Schindler R. Wilkinson D, et al. Int J Geriatr Psychiatry. 2010 Mar;25(3):305-13. doi: 10.1002/gps.2340. Int J Geriatr Psychiatry. 2010. PMID: 19623601 Clinical Trial.

4

Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease.

Waldemar G, Gauthier S, Jones R, Wilkinson D, Cummings J, Lopez O, Zhang R, Xu Y, Sun Y, Knox S, Richardson S, Mackell J. Waldemar G, et al. Among authors: wilkinson d. Int J Geriatr Psychiatry. 2011 Feb;26(2):150-7. doi: 10.1002/gps.2507. Int J Geriatr Psychiatry. 2011. PMID: 20597141 Clinical Trial.

5

Effect of donepezil on cognition in severe Alzheimer's disease: a pooled data analysis.

Cummings J, Jones R, Wilkinson D, Lopez O, Gauthier S, Waldemar G, Zhang R, Xu Y, Sun Y, Richardson S, Mackell J. Cummings J, et al. Among authors: wilkinson d. J Alzheimers Dis. 2010;21(3):843-51. doi: 10.3233/JAD-2010-100078. J Alzheimers Dis. 2010. PMID: 20634594 Clinical Trial.

6

Predicting cognitive decline in Alzheimer's disease: an integrated analysis.

Lopez OL, Schwam E, Cummings J, Gauthier S, Jones R, Wilkinson D, Waldemar G, Zhang R, Schindler R. Lopez OL, et al. Among authors: wilkinson d. Alzheimers Dement. 2010 Nov;6(6):431-9. doi: 10.1016/j.jalz.2010.04.003. Alzheimers Dement. 2010. PMID: 21044773 Review.

7

Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.

Wilkinson DG, Francis PT, Schwam E, Payne-Parrish J. Wilkinson DG, et al. Drugs Aging. 2004;21(7):453-78. doi: 10.2165/00002512-200421070-00004. Drugs Aging. 2004. PMID: 15132713 Review.

8

Collaborative research between academia and industry using a large clinical trial database: a case study in Alzheimer's disease.

Jones R, Wilkinson D, Lopez OL, Cummings J, Waldemar G, Zhang R, Mackell J, Gauthier S. Jones R, et al. Among authors: wilkinson d. Trials. 2011 Oct 26;12:233. doi: 10.1186/1745-6215-12-233. Trials. 2011. PMID: 22029822 Free PMC article.

9

Memantine in patients with moderate to severe Alzheimer's disease: meta-analyses using realistic definitions of response.

Wilkinson D, Wirth Y, Goebel C. Wilkinson D, et al. Dement Geriatr Cogn Disord. 2014;37(1-2):71-85. doi: 10.1159/000353801. Epub 2013 Oct 3. Dement Geriatr Cogn Disord. 2014. PMID: 24107324 Review.

10

Analysis of the effect of memantine in reducing the worsening of clinical symptoms in patients with moderate to severe Alzheimer's disease.

Wilkinson D, Andersen HF. Wilkinson D, et al. Dement Geriatr Cogn Disord. 2007;24(2):138-45. doi: 10.1159/000105162. Epub 2007 Jul 4. Dement Geriatr Cogn Disord. 2007. PMID: 17622761

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,146 results

Search Page

Filters